Cargando…

Azithromycin/hydroxychloroquine: Torsade-de-pointes following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677447/ http://dx.doi.org/10.1007/s40278-020-86332-7

Ejemplares similares

Azithromycin/hydroxychloroquine: Torsades de pointes following off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Torsades-de-pointes following off label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Torsade de pointes, premature atrial contraction and right bundle branch block following off-label use: 4 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Methemoglobinemia following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: DRESS syndrome following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac disorder followed by off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Cardiac disorders following off label use: 5 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine/oseltamivir: Urticarial reactions following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac arrest following off-label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Elevated liver enzymes following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine off label use: Pustular psoriasis following misuse: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine/propofol: Hypoglycaemia and cardiotoxicities following off label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Ventricular arrhythmias following off-label use in COVID-19: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine/propofol: Off-label use and propofol infusion syndrome: case report
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine: Ventricular tachycardia and off-label use: 2 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Acute generalised exanthematous pustulosis and off-label use : case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Brugada-like ECG pattern following off-label use: case report
Publicado: (2021)

Multiple drugs: QTc prolongation leading to torsades-de-pointes and off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Azithromycin/eculizumab/hydroxychloroquine: Normocytic anaemia, lack of efficacy and off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qv0b36445sscmv37vppknfse89